Morgens Waterfall Vintiadis & Co’s Medtronic MDT Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16,800	Closed	-$2.11M	–	32
2021 Q3	$2.11M	Hold	16,800	–	–	1.09%	26
2021 Q2	$2.08M	Hold	16,800	–	–	1.07%	26
2021 Q1	$1.99M	Buy	+16,800	New	+$1.97M	1.1%	28
2020 Q1	–	Sell	-15,000	Closed	-$1.7M	–	45
2019 Q4	$1.7M	Hold	15,000	–	–	1.16%	31
2019 Q3	$1.63M	Hold	15,000	–	–	1.25%	30
2019 Q2	$1.46M	Buy	+15,000	New	+$1.37M	1.01%	33
2015 Q2	–	Sell	-55,000	Closed	-$4.29M	–	51
2015 Q1	$4.29M	Hold	55,000	–	–	2.75%	12
2014 Q4	$3.97M	Hold	55,000	–	–	2.22%	19
2014 Q3	$3.41M	Buy	+55,000	New	+$3.5M	2.39%	19

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's MDT Position: Q4 2021 in Review

Morgens Waterfall Vintiadis & Co sold out of Medtronic (MDT) in Q4 2021, closing a stake of 16,800 shares — an estimated $2.11M sold.

Morgens Waterfall Vintiadis & Co first reported a position in MDT in Q3 2014 and held it in 9 quarters. The position peaked at $4.29M in Q1 2015. 2,060 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

Morgens Waterfall Vintiadis & Co reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
Morgens Waterfall Vintiadis & Co sold 16,800 Medtronic shares in Q4 2021, an estimated $2.11M.
Morgens Waterfall Vintiadis & Co first reported a position in Medtronic in Q3 2014 and held it in 9 quarters.
Morgens Waterfall Vintiadis & Co's Medtronic position peaked at $4.29M in Q1 2015.
2,060 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q4 2021, filed 14 Feb 2022.